Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Pulmonary Hypertension

  Free Subscription


11.02.2019

1 Am J Cardiol
1 Am J Case Rep
1 Am J Health Syst Pharm
1 Am J Physiol Lung Cell Mol Physiol
1 Arch Biochem Biophys
1 Arch Cardiol Mex
1 BMC Cardiovasc Disord
1 BMJ Case Rep
1 Catheter Cardiovasc Interv
1 Chest
2 Clin Cardiol
1 Curr Opin Nephrol Hypertens
1 Curr Pharm Biotechnol
1 Eur J Cardiothorac Surg
1 Eur Respir Rev
1 Exp Biol Med (Maywood)
1 Front Immunol
1 Front Pharmacol
1 Indian Heart J
1 J Cardiovasc Med (Hagerstown)
2 JACC Cardiovasc Interv
1 Kardiologiia
1 Lakartidningen
1 Mol Genet Metab Rep
1 Pediatr Res
1 Physiol Rep
1 Phytomedicine
3 Pulm Circ
1 Respir Med
1 Rinsho Ketsueki
1 Semin Nephrol
1 Zhonghua Jie He He Hu Xi Za Zhi
1 Zhonghua Xin Xue Guan Bing Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Cardiol

  1. ZWIJNENBURG RD, Baggen VJM, Witsenburg M, Boersma E, et al
    Risk Factors for Pulmonary Hypertension in Adults After Atrial Septal Defect Closure.
    Am J Cardiol. 2019 Jan 24. pii: S0002-9149(19)30103.
    PubMed     Text format     Abstract available


    Am J Case Rep

  2. HINRICHS L, Horacek M, Neudorf U, Schlosser T, et al
    Diagnostic Work-Up of Pulmonary Hypertension - Think About Shunt Flow! A Case Report.
    Am J Case Rep. 2019;20:154-158.
    PubMed     Text format     Abstract available


    Am J Health Syst Pharm

  3. NOEL ZR
    Safety concerns regarding selexipag in pulmonary arterial hypertension.
    Am J Health Syst Pharm. 2018;75:420.
    PubMed     Text format    


    Am J Physiol Lung Cell Mol Physiol

  4. BARMAN SA, Li X, Haigh S, Kondrikov D, et al
    Galectin-3 is Expressed in Vascular Smooth Muscle Cells and Promotes Pulmonary Hypertension through changes in Proliferation, Apoptosis and Fibrosis.
    Am J Physiol Lung Cell Mol Physiol. 2019 Feb 6. doi: 10.1152/ajplung.00186.2018.
    PubMed     Text format     Abstract available


    Arch Biochem Biophys

  5. TRUONG L, Zheng YM, Wang YX
    Mitochondrial Rieske iron-sulfur protein in pulmonary artery smooth muscle: A key primary signaling molecule in pulmonary hypertension.
    Arch Biochem Biophys. 2019 Jan 30. pii: S0003-9861(18)30669.
    PubMed     Text format     Abstract available


    Arch Cardiol Mex

  6. RODRIGUEZ-ALMENDROS N, Toapanta-Yanchapaxi LN, Aguirre Valadez J, Espinola Zavaleta N, et al
    [Portopulmonary hypertension: Updated review].
    Arch Cardiol Mex. 2018;88:25-38.
    PubMed     Text format     Abstract available


    BMC Cardiovasc Disord

  7. PUDASAINI B, Yang GL, Yang C, Guo J, et al
    Characteristics of exercise capacity in female systemic lupus erythematosus associated pulmonary arterial hypertension patients.
    BMC Cardiovasc Disord. 2018;18:56.
    PubMed     Text format     Abstract available


    BMJ Case Rep

  8. SHARMA A, Pandey NN, Kumar S
    Pulmonary capillary haemangiomatosis causing pulmonary arterial hypertension: a clinician's conundrum.
    BMJ Case Rep. 2018;2018.
    PubMed     Text format    


    Catheter Cardiovasc Interv

  9. LIGON RA, Petit CJ
    Working backward: Retrograde balloon angioplasty of atretic arteries in chronic thromboembolic pulmonary hypertension.
    Catheter Cardiovasc Interv. 2019 Feb 5. doi: 10.1002/ccd.28115.
    PubMed     Text format     Abstract available


    Chest

  10. DODSON MW, Allen-Brady K, Brown LM, Elliott CG, et al
    Chronic Thromboembolic Pulmonary Hypertension Cases Cluster in Families.
    Chest. 2019;155:384-390.
    PubMed     Text format     Abstract available


    Clin Cardiol

  11. DANDEL M, Hetzer R
    Diagnostic and Prognostic Value of Echocardiography in Pulmonary Arterial Hypertension.
    Clin Cardiol. 2018 Aug 1. doi: 10.1002/clc.23036.
    PubMed     Text format     Abstract available

  12. KOESTENBERGER M, Avian A, Meinel K, Sallmon H, et al
    Author Response to LTE CLC-18-0673 entitled "Diagnostic and Prognostic Value of Echocardiography in Pulmonary Arterial Hypertension".
    Clin Cardiol. 2018 Aug 1. doi: 10.1002/clc.23038.
    PubMed     Text format     Abstract available


    Curr Opin Nephrol Hypertens

  13. DUBIN RF
    Application of echocardiographic data in patients with chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2018 May 16. doi: 10.1097/MNH.0000000000000419.
    PubMed     Text format     Abstract available


    Curr Pharm Biotechnol

  14. GUERRA G, Perrotta F, Testa G
    Circulating Endothelial Progenitor Cells Biology and Regenerative Medicine in Pulmonary Vascular Diseases.
    Curr Pharm Biotechnol. 2018;19:700-707.
    PubMed     Text format     Abstract available


    Eur J Cardiothorac Surg

  15. TOTARO P, Pelenghi S
    Patient-prosthesis mismatch after mitral valve replacement: complex enigma with more than one solution.
    Eur J Cardiothorac Surg. 2018 Apr 19. pii: 4978191. doi: 10.1093.
    PubMed     Text format    


    Eur Respir Rev

  16. PRICE LC, Seckl MJ, Dorfmuller P, Wort SJ, et al
    Tumoral pulmonary hypertension.
    Eur Respir Rev. 2019;28.
    PubMed     Text format     Abstract available


    Exp Biol Med (Maywood)

  17. CAI G, Liu J, Wang M, Su L, et al
    Mutual promotion of FGF21 and PPARgamma attenuates hypoxia-induced pulmonary hypertension.
    Exp Biol Med (Maywood). 2019 Feb 2:1535370219828692.
    PubMed     Text format     Abstract available


    Front Immunol

  18. MICKAEL CS, Graham BB
    The Role of Type 2 Inflammation in Schistosoma-Induced Pulmonary Hypertension.
    Front Immunol. 2019;10:27.
    PubMed     Text format     Abstract available


    Front Pharmacol

  19. FAN F, Tian H, Geng J, Deng J, et al
    Mechanism of Beraprost Effects on Pulmonary Hypertension: Contribution of Cross-Binding to PGE2 Receptor 4 and Modulation of O2 Sensitive Voltage-Gated K(+) Channels.
    Front Pharmacol. 2019;9:1518.
    PubMed     Text format     Abstract available


    Indian Heart J

  20. BHYRAVAVAJHALA S, Yerram S, Galla R, Kotapati VSK, et al
    Reliability of Doppler echocardiography in the assessment of high pulmonary vascular resistance in patients with severe pulmonary arterial hypertension.
    Indian Heart J. 2018;70 Suppl 3:S241-S244.
    PubMed     Text format     Abstract available


    J Cardiovasc Med (Hagerstown)

  21. ALBANI S, Biondi F, Stolfo D, Lo Giudice F, et al
    Chronic thromboembolic pulmonary hypertension (CTEPH): what do we know about it? A comprehensive review of the literature.
    J Cardiovasc Med (Hagerstown). 2019 Jan 31. doi: 10.2459/JCM.0000000000000774.
    PubMed     Text format     Abstract available


    JACC Cardiovasc Interv

  22. ZHANG H, Zhang J, Chen M, Xie DJ, et al
    Pulmonary Artery Denervation Significantly Increases 6-Min Walk Distance for Patients With Combined Pre- and Post-Capillary Pulmonary Hypertension Associated With Left Heart Failure: The PADN-5 Study.
    JACC Cardiovasc Interv. 2019;12:274-284.
    PubMed     Text format     Abstract available

  23. DIMOPOULOS K, Ernst S, McCabe C, Kempny A, et al
    Pulmonary Artery Denervation: A New, Long-Awaited Interventional Treatment for Combined Pre- and Post-Capillary Pulmonary Hypertension?
    JACC Cardiovasc Interv. 2019;12:285-288.
    PubMed     Text format    


    Kardiologiia

  24. CHERNYAVSKIY AM, Edemskiy AG, Novikova NV, Romanov AB, et al
    Radiofrequency Pulmonary Artery Ablation for Treatment of Residual Pulmonary Hypertension After Pulmonary Endarterectomy.
    Kardiologiia. 2018;58:15-21.
    PubMed     Text format     Abstract available


    Lakartidningen

  25. RADEGRAN G
    [Riskstratification in pulmonary arterial hypertension - renders better treatment and prognosis at highly specialised centers].
    Lakartidningen. 2018;115.
    PubMed     Text format     Abstract available


    Mol Genet Metab Rep

  26. APATEAN D, Rakic B, Brunel-Guitton C, Hendson G, et al
    Congenital lactic acidosis, cerebral cysts and pulmonary hypertension in an infant with FOXRED1 related complex I deficiency.
    Mol Genet Metab Rep. 2019;18:32-38.
    PubMed     Text format     Abstract available


    Pediatr Res

  27. HAYASAKA I, Cho K, Akimoto T, Ikeda M, et al
    Genetic basis for childhood interstitial lung disease among Japanese infants and children.
    Pediatr Res. 2018;83:477-483.
    PubMed     Text format     Abstract available


    Physiol Rep

  28. MAKKER K, Afolayan AJ, Teng RJ, Konduri GG, et al
    Altered hypoxia-inducible factor-1alpha (HIF-1alpha) signaling contributes to impaired angiogenesis in fetal lambs with persistent pulmonary hypertension of the newborn (PPHN).
    Physiol Rep. 2019;7:e13986.
    PubMed     Text format     Abstract available


    Phytomedicine

  29. CHANG H, Chang CY, Lee HJ, Chou CY, et al
    Magnolol ameliorates pneumonectomy and monocrotaline-induced pulmonary arterial hypertension in rats through inhibition of angiotensin II and endothelin-1 expression.
    Phytomedicine. 2018;51:205-213.
    PubMed     Text format     Abstract available


    Pulm Circ

  30. BARNIKEL M, Kneidinger N, Klenner F, Waelde A, et al
    EXPRESS: Real-life data on Selexipag for the treatment of Pulmonary Hypertension.
    Pulm Circ. 2019 Feb 4:2045894019832199. doi: 10.1177/2045894019832199.
    PubMed     Text format    

  31. FORIS V, Brcic L, Douschan P, Kovacs G, et al
    EXPRESS: Advanced interstitial lung fibrosis with emphysema and pulmonary hypertension with no evidence for interstitial lung disease on high resolution CT.
    Pulm Circ. 2019 Feb 7:2045894019832214. doi: 10.1177/2045894019832214.
    PubMed     Text format    

  32. SOHN DW, Park JB, Lee SP, Kim HK, et al
    EXPRESS: Clinical Implication of Right-Sided Augmentation Pressure in Patients with Pulmonary Hypertension.
    Pulm Circ. 2019 Feb 5:2045894019833352. doi: 10.1177/2045894019833352.
    PubMed     Text format    


    Respir Med

  33. HARDER EM, Fares WH
    Hospitalizations with hereditary hemorrhagic telangiectasia and pulmonary hypertension in the United States from 2000 to 2014.
    Respir Med. 2019;147:26-30.
    PubMed     Text format     Abstract available


    Rinsho Ketsueki

  34. MATSUMURA I
    [Management of cardiovascular complications in CML patients treated with tyrosine kinase inhibitors].
    Rinsho Ketsueki. 2018;59:13-26.
    PubMed     Text format     Abstract available


    Semin Nephrol

  35. TANAKA T, Eckardt KU
    HIF Activation Against CVD in CKD: Novel Treatment Opportunities.
    Semin Nephrol. 2018;38:267-276.
    PubMed     Text format     Abstract available


    Zhonghua Jie He He Hu Xi Za Zhi

  36. ZHAO QH, Wu WH, Gong SG, Jiang R, et al
    [Clinical and imaging features of pulmonary veno-occlusive disease and pulmonary capillary hemangioma].
    Zhonghua Jie He He Hu Xi Za Zhi. 2018;41:41-46.
    PubMed     Text format     Abstract available


    Zhonghua Xin Xue Guan Bing Za Zhi

  37. ZHANG XM, Zhuang Q, Yang MH, Wang W, et al
    [Value of four-dimensional echocardiography combined with speckle tracking technique on the assessment of right heart function and prognosis in patients with pulmonary arterial hypertension].
    Zhonghua Xin Xue Guan Bing Za Zhi. 2018;46:965-971.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: